15-min delayed · Jul 28, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 2 firms covering TriMas Corporation, 2 rate it Buy or better, 0 sit at Hold, and 0 rate it Sell or worse, a strong buy consensus. Targets are tightly clustered, $38.00 to $45.00, so the covering firms are broadly aligned. The average target of $41.50 sits 3% above the current $40.21. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $0.52 next quarter toward $2.17 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS2 ratings
Strong Buy
Strong Buy00%
Buy2100%
Hold00%
Sell00%
Strong Sell00%
Based on 2 analysts giving stock ratings to TriMas Corporation.
As of Jul, 2 of 2 firms rate TRS a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
TRS EPS & revenue forecast
EPS · NEXT QUARTER
$0.52
Range $0.50 – $0.54 · 2 analysts · -15% YoY
Next period, 2 analysts expect TriMas Corporation to earn $0.52 a share (range $0.50 – $0.54), versus $0.61 a year earlier. Full-year consensus is $1.67, growing to $2.17 the year after.
REVENUE · NEXT QUARTER
$173.9M
Range $172.5M – $175.4M · 2 analysts · -35% YoY
Revenue is expected to reach $173.9M (range $172.5M – $175.4M), -35.4% year-over-year. Full-year consensus is $679.5M, rising to $713.5M next year.
Top analysts covering TriMas Corporation
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on TRS.
#1
Hamed Khorsand
BWS Financial · Rank #14
Buy
$45.00+11.9% to target
Overall win rate
52%
+ Follow
#2
KN
Ken Newman
Keybanc
Buy
$38.00-5.5% to target
Coverage
—
+ Follow
TRS stock forecast FAQ
What is TRS's average 12-month price target?+
The 2 analysts with a live target average $41.50 for TriMas Corporation over the next 12 months, ranging from a $45.00 high to a $38.00 low.
Is TRS stock a Buy, Sell or Hold right now?+
The current consensus is Strong Buy. Of the 2 analyst ratings, 2 are Buy or Strong Buy, 0 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for TRS?+
The Street-high target is $45.00 (BWS Financial), and the Street-low is $38.00 (Keybanc). The average of all 2 active targets is $41.50.
How many Wall Street analysts cover TRS?+
2 analysts have an active rating on TriMas Corporation, and 2 firms carry a live 12-month price target.
Who is the most accurate analyst covering TRS?+
Among analysts who currently cover TRS, Hamed Khorsand of BWS Financial has the strongest overall Quantellect track record (Rank #14). Their current call is Buy with a $45.00 target.
What is TriMas Corporation's projected EPS for next quarter?+
The consensus estimate is $0.52 per share (range $0.50 – $0.54) across 2 analysts. Full-year EPS is projected at $1.67, rising to $2.17 the following year.
How much revenue is TriMas Corporation expected to report next quarter?+
Consensus revenue is $173.9M (range $172.5M – $175.4M). Full-year revenue is projected at $679.5M, growing to $713.5M next year.
Have analysts been upgrading or downgrading TRS lately?+
As of Jul, 2 of 2 firms rate TRS a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their TRS calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
